Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$43,098
-$21,515 QoQ
Shares Held
275
-35.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,444
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MASECO LLP holds $4,191,440 across 11 Drug Manufacturers - General names. NVS ranks #9 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,316 | $1,387,259 | |
| 2 | ABBV |
AbbVie Inc.
|
5,446 | $1,370,431 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,873 | $754,680 | |
| 4 | JNJ |
Johnson & Johnson
|
791 | $200,890 | |
| 5 | PFE |
Pfizer Inc
|
7,281 | $175,326 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,352 | $77,902 | |
| 7 | AMGN |
Amgen Inc
|
200 | $72,424 | |
| 8 | LLY |
ELI LILLY & Co
|
39 | $46,777 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,098 | 275 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $64,613 | 423 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $71,692 | 520 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $54,245 | 423 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,060 | 298 | Shares | Sole | 2025-07-15 | |
| No filing history on record for this holder in this stock. | ||||||